Paravertebral catheter
DeviceA catheter is placed ultrasound guided at the T5 paravertebral level
NCT Number: NCT02361775
Level I randomized prospective outcomes study comparing two groups of patients. One group will receive Dilaudid patient controlled analgesia (PCA) post-operatively. The other will receive an ultrasound guided paravertebral block with indwelling paravertebral catheter with an infusion of 0.2% Ropivicaine post-operatively and a PCA.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Early Phase 1
Design: Level I randomized prospective outcomes study comparing two groups of patients. One group will receive Dilaudid patient controlled analgesia (PCA) post-operatively. The other will receive an ultrasound guided paravertebral block with indwelling paravertebral catheter with an infusion of 0.2% Ropivicaine post-operatively and a PCA.
Sample Size: 50 patients Study Duration: Approximately 24 months Population:. Patients presenting to the University of Minnesota Medical Center for elective Video Assisted Thoracoscopic Surgery (VATS), for thoracic, lung, or mediastinal lesions or masses.
Primary Objective: To determine if post-operative paravertebral catheters in patients with elective VATS procedures result in decreased pain compared to patients treated with PCA for post-operative pain.
Secondary Objectives:
Specific Aims:
Primary Hypothesis: Paravertebral catheters will result in improved pain control relative to PCA for post-operative pain from thoracic surgery.
Secondary Hypothesis: Paravertebral catheters will result in fewer hospital days and improved subjective respiratory function compared to patients in the PCA group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A catheter is placed ultrasound guided at the T5 paravertebral level
opioid pca consisting of hydromorphone
0.2% ropivacaine infused through paravertebral catheter
Other names: Naropin
Elastomeric pump connected to paravertebral catheter
Other names: On Q
Time frame: 0-24 hours after surgery
pain at movement or maximum in first 24 hours after surgery
Time frame: the first 5 days after surgery
total opioids converted to morphine equivalents
Time frame: time until patient is ready to be discharged or is discharged, expected 5 days
participants will be followed for duration of stay expected 5 days
Time frame: the first 5 days postoperatively
the number of patients who have nausea and or vomiting.
University of Minnesota
Other
Ultrasound Guided Paravertebral Catheter Versus Patient Controlled Analgesia for Postoperative Pain Control in Video Assisted Thoracoscopic Surgery: A Prospective Outcomes Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735884
Acute Pain, Femoral Fractures
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07335159
Acute Pain, Agnosia
Tallahassee, Florida, United States
View Trial DetailsNCT07500454
Acute Pain, Neurologic Manifestations
Mexico City, Mexico
View Trial DetailsNCT05229055
Acute Pain, Neurologic Manifestations
Monastir, Tunisia
View Trial Details